Disposition of Pharmacologically Active Dietary Isoflavones in Biological Systems

Show simple item record

dc.contributor.author Wahajuddin
dc.contributor.author Taneja, Isha
dc.contributor.author Arora, Sumit
dc.contributor.author Raju, K S R
dc.contributor.author Siddiqui, Nida
dc.date.accessioned 2014-08-28T09:11:11Z
dc.date.available 2014-08-28T09:11:11Z
dc.date.issued 2013
dc.identifier.citation Current Drug Metabolism, 2013, 14(4), 369-380 en
dc.identifier.uri http://hdl.handle.net/123456789/1380
dc.description.abstract Dietary isoflavones, popularly known as phytoestrogens, represent one of the most biologically active classes of flavonoids. Numerous in vitroandin vivostudies provide convincing evidence regarding their beneficial effects on human health. These isoflavones are increasingly being investigated as potential alternate therapies for a range of hormone-dependent conditions, including cancer, menopausal symptoms, osteoporosis and cardiovascular diseases. However, they exhibit poor oral bioavailability which limits their clinical utility in humans. The reason being, they are substrates of a plethora of enzymes and transporters and undergo extensive conjugative metabolismwhich facilitate their rapid elimination from biological systems. In addition, a number of experimental studies have also revealed that these isoflavones are potent inhibitors of various cytochrome P450 isoforms and transporters which play an important role in the disposition of many commonly prescribed drugs. Thus, there arise chances of observing clinically relevant herb-drug interactions which could sometimes be life-threatening. This review gives a comprehensive understanding of these dietary phytoestrogens with regard to their absorption, biodistribution and the role of enzyme-transporter interplay affecting their disposition in biological systems. Further, the effects of these phytoestrogens on the activity and kinetics of drug metabolizing enzymes and various clinically relevant influx/efflux transporters and the resulting diet-drug interactions have also been discussed. en
dc.format.extent 206885 bytes
dc.format.mimetype application/pdf
dc.language.iso en en
dc.relation.ispartofseries CSIR-CDRI Communication No. 8436 en
dc.subject Conjugates en
dc.subject Disposition en
dc.subject Efflux transporters en
dc.subject Enteric recirculation en
dc.subject Isoflavones en
dc.subject Phase II metabolism en
dc.title Disposition of Pharmacologically Active Dietary Isoflavones in Biological Systems en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account